| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5529791 | BAUSCH | Extended release form of diltiazem |
Jun, 2013
(10 years ago) | |
Tiazac is owned by Bausch.
Tiazac contains Diltiazem Hydrochloride.
Tiazac has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Tiazac are:
- US5529791
Tiazac was authorised for market use on 11 September, 1995.
Tiazac is available in capsule, extended release;oral dosage forms.
The generics of Tiazac are possible to be released after 25 June, 2013.
Drugs and Companies using DILTIAZEM HYDROCHLORIDE ingredient
Market Authorisation Date: 11 September, 1995
Treatment: NA
Dosage: CAPSULE, EXTENDED RELEASE;ORAL
How can I launch a generic of TIAZAC before it's drug patent expiration?
More Information on Dosage
TIAZAC family patents
